American Society of Hirudotherapy

Diversity and antibiograms of bacteria isolated from cutaneous leishmaniasis wounds in the Nkwanta South District of Ghana.

Research article published in Archives of microbiology (2023)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportAntimicrobial ResistanceGenomics & ProteomicsClinical TrialsSafety & Infection ControlYeboaa C et al. · Archives of microbiology, 2023

Abstract

Leishmaniasis is a vector-borne disease caused by an intracellular protozoan parasite. The presence of secondary bacterial infections in cutaneous leishmaniasis wounds exacerbate lesion development and could lead to delay in the healing process. This study sought to determine the resistance patterns of bacteria co-infecting cutaneous leishmaniasis wounds from selected communities in the Nkwanta district. Various bacteria were isolated and characterized from exudates obtained from wound swabs collected with sterile cotton tipped applicators. Confirmation of bacterial identity was done using the analytical profile index and the matrix-assisted laser desorption/ionization time of flight mass spectrometry. Antibiotic susceptibility tests were performed using agar disc diffusion method according to the Clinical and Laboratory Standards Institute breakpoint values. A total of eleven (11) secondary bacterial species (spp) were isolated from the 33 wound samples that tested positive for Leishmania kinetoplast DNA, among which Staphylococcus aureus was the most predominant (31%). The pathogenic bacteria that colonized the wounds included Bacillus subtilis (23.8%), Pantoea species (11.9%), Klebsiella pneumoniea (7.1%), Enterobacter cloacae (7.1%), Aeromonas species (4.8%), Serratia marcescens (4.8%), Serratia liquefacien (2.4%), Serratia plymutheca (2.4%), Providencia rettgeri (2.4%) and Cronobacter species (2.4%). Most of the isolates were resistant to beta-lactam antibiotics and the third-generation cephalosporin. Notably, 84.6% of the S. aureus isolates were methicillin and ciprofloxacin resistant whilst 92.3% were resistant to ampicillin. About sixty-nine percent (69.2%) showed intermediate susceptibility to Erythromycin. Additionally, S. plymutheca was resistant to all the test antibiotics. This study suggests colonization of cutaneous leishmaniasis wounds with varied bacterial species that are mostly resistant to beta-lactam group of antibiotics.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsHumansStaphylococcus aureusGhanaBacteriaAnti-Bacterial AgentsMicrobial Sensitivity Testsbeta-LactamsLeishmaniasis, Cutaneous

Summary

Leishmaniasis is a vector-borne disease caused by an intracellular protozoan parasite. The presence of secondary bacterial infections in cutaneous leishmaniasis wounds exacerbate lesion development and could lead to delay in the healing process.

Why This Matters for Hirudotherapy

This microbiological study characterized bacteria co-infecting cutaneous leishmaniasis wounds in Ghana, isolating eleven secondary species from Leishmania-positive wound swabs, with Staphylococcus aureus most predominant, and reporting widespread resistance to beta-lactams and third-generation cephalosporins (including high rates of methicillin- and ciprofloxacin-resistant S. aureus). Its relevance to hirudotherapy is indirect but instructive on wound infection and antibiograms: it shows how chronic skin wounds become colonized by drug-resistant flora, an issue ASH must weigh whenever leeches are applied to compromised or open tissue, where secondary infection and resistance patterns govern prophylaxis choices. The caveat is substantial: this study concerns leishmaniasis lesions and their own bacterial colonizers (incidentally including a small fraction of Aeromonas species), not medicinal leeches or leech-associated infection, and it reports a single-district resistance snapshot rather than any treatment outcome.

Citation

Diversity and antibiograms of bacteria isolated from cutaneous leishmaniasis wounds in the Nkwanta South District of Ghana.

Yeboaa C et al. · Archives of microbiology, 2023

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.